Drug intelligence / Profile preview

polymerized house dust mite + grass pollen allergen extract

Development stage
Unknown
Lead developer
Inmunotek
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Polymerized house dust mite + grass pollen allergen extract is a subcutaneous allergen immunotherapy (SCIT) product developed by Inmunotek, S.L. It is a combination allergoid vaccine containing house dust mite (HDM) extracts—specifically *Dermatophagoides pteronyssinus* and *D. farinae*—and grass pollen extracts. These extracts are chemically modified through glutaraldehyde cross-linking (polymerization), which reduces their IgE-binding capacity (improving safety) while preserving their ability to induce an immune response. This process also stabilizes the mixture by significantly reducing the proteolytic activity of HDM allergens, preventing the degradation of grass pollen allergens. The therapy works by inducing immune tolerance, characterized by the production of allergen-specific IgG antibodies, T-cell proliferation, and the secretion of the anti-inflammatory cytokine IL-10. It is primarily indicated for the treatment of allergic rhinitis, allergic rhinoconjunctivitis, and mild-to-moderate asthma in patients polysensitized to both house dust mites and grass pollen.

Other names
polymerized HDM and grass pollen extractsubcutaneous polymerized allergen immunotherapy with a mixture of grass pollen and house dust mite extracts
02

Targets

BCR (Immunoglobulin G B Cell Receptor)IL10 (Interleukin-10)TCR (T cell antigen receptor complex)

Beyond the preview

Go deeper on polymerized house dust mite + grass pollen allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polymerized house dust mite + grass pollen allergen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call